China graft probes a tough tonic as pharma margins bounce
June 10, 2015 at 17:00 PM EDT
SHANGHAI, June 11 (Reuters) - Sales growth is picking up speed at Chinese drugs firms, and margins are widening, in a sign that the world's second-largest pharmaceuticals market may be rebounding from a crackdown on corruption and high prices.
